UBS Conference Roundup: Roche; Waters; Cepheid; Thermo Fisher Scientific; Bruker; Affymetrix; Qiagen; Myriad Genetics; Celera; Genzyme
September 23, 2010
UBS Conference Roundup: Roche; Waters; Cepheid; Thermo Fisher Scientific; Bruker; Affymetrix; Qiagen; Myriad Genetics; Celera; Genzyme
This week executives from several firms in the molecular research tools and molecular diagnostics fields made their pitch to investors at the annual UBS Global Life Sciences Conference.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- IVD Industry Flourishes as Some Clinical Labs Flounder. But It's Not All Bad
August 6, 2010 / The Sample - JP Morgan Healthcare Conference, Day One: Myriad Genetics; Bruker; Genomic Health; Qiagen; Waters
January 8, 2013 / GenomeWeb Daily News - Big Names Join Clinical Proteomics Push in 2011, Offering Ray of Optimism Amidst Difficult Year
January 6, 2012 / ProteoMonitor - Credit Suisse Initiates Coverage of Illumina, Life Tech, Thermo Fisher, Cepheid, Qiagen, and Waters
December 15, 2011 / GenomeWeb Daily News - Triple Quads Take the Stage at ASMS 2013 as Vendors Continue Piecing Together Clinical MS Platforms
June 14, 2013 / ProteoMonitor